THE inoculation plan of the NCAA for its student athletes has hit a snag and is now expected to happen in the fourth quarter of this year.
A highly-reliable source yesterday told Malaya-Business Insight that the league’s vaccination program will not likely push through next month due to a delay caused by a spike in COVID-19 cases in India, where the jabs will come from.
“Iyong aming vaccine, baka fourth quarter pa dumating. Nagkaroon ng problema doon sa source, sa kanila nagka-delay kasi iyong Serum Institute of India, doon nagpapagawa iyang mga Covovax, AstraZeneca,” the source, who spoke on condition of anonymity, said.
“Magkakaroon ng delay sa kanila kasi nagkaroon din ng surge sa India and uunahin ng gobyerno nila ay iyong for domestic use.”
The country’s oldest collegiate league is linking up with Dr. Jose Paulo Campos, league Policy Board member and Emilio Aguinaldo College president, whose family partly owns Unilab, the distributor of the Covovax vaccine brand, to immunize its players.
The NCAA is plodding on with its 96th season with online and hybrid events due to the health risks and uncertainties posed by the deadly COVID-19 pandemic.
Set to be hosted by Letran, the new season, set to get going virtually in the first week of May, has been reset to a later date.